Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.
There is currently no manufacturer warning information available for this drug.
TL-HEM 150 is indicated in the treatment of most megaloblastic, macrocytic and iron-deficiency anemias, in the anemias of pregnancy, in those anemias occurring in a variety of malabsorption syndromes, and those of nutritional origin. It is a useful adjuvant in patients in whom erythropoiesis is suppressed due to severe infections, malignancies or to the toxic effects of certain chemotherapeutic agents. A deficiency of Vitamin E may increase the fragility of red blood cells, with resultants enhanced hemolysis.
TL-Hem 150 is a hematinic preparation containing multiple ingredients essential to normal erythropoiesis, plus a stool softener to counteract the possible constipating effects of iron. Vitamin C is present to aid the absorption of iron.
TL-HEM 150 caplets are oval, beige, film-coated caplets debossed “TL606” .
| Each caplet for oral administration contains: | |
| Vitamin C (ascorbic acid) | 500 mg |
| Vitamin E (dl-alpha tocopheryl acetate) | 30 IU |
| Folic Acid | 1 mg |
| Vitamin B12 (cyanocobalamin) | 60 mcg |
| Biotin | 150 mcg |
| Iron (carbonyl iron) | 150 mg |
| Copper (cupric sulfate) | 3 mg |
| Docusate Sodium | 50 mg |
Inactive Ingredients
Microcrystalline Cellulose, Polyvinyl Alcohol, TriPotassium Citrate, Citric Acid, Titanium Dioxide, Povidone, Acacia, Stearic Acid, Fumed Silica, Magnesium Stearate, Talc, Polyethylene Glycol, FD&C Yellow #6, FD&C Blue #2.